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 سرطان اخلاليا الصغرية يف الغدد الصم العصبية من
عنق الرحم تشابه ورم عنق الرحم الليفي
تقرير حالة نادرة
موكتا بوجاين، كانيكا �سينغ، فار�سا ت�سوهان، رينا ت�ساوال، را�سمي اأهوجا
abstract: Primary neuroendocrine tumours of the cervix are extremely rare, with an incidence of only 0.5–1%; 
as such, these entities can present a clinical and diagnostic challenge. Small-cell neuroendocrine carcinomas of 
the cervix are highly aggressive tumours that have a tendency to metastasise. We report a 44-year-old woman who 
presented to the Gynaecology Clinic of the Employees State Insurance Corporation Medical College & Hospital, 
Faridabad, India, in 2016 with menorrhagia. Based on a clinical examination, she was provisionally diagnosed with 
a cervical fibroid. However, a biopsy revealed features of a small-cell neuroendocrine carcinoma of the cervix which 
was subsequently confirmed via immunohistochemistry. An accurate diagnosis of a neuroendocrine carcinoma is 
vital as it forms the basis for treatment decisions as well as informing predictions for long-term survival.
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امللخ�ص: تعترب اأورام الغدد ال�سم الع�سبية االأولية من عنق الرحم نادرة للغاية مع ن�سبة حدوث �سنوية تعادل فقط %1-0.5. وعلى هذا 
النحو، ميكن لهذه االأورام اأن متثل حتديا �رصيريا وت�سخي�سيا. و لدى �رصطان اخلاليا ال�سغرية من هذه االأورام ميول عدوانية للغاية و�رصعة 
يف انت�سار الثانويات. هذا تقرير حالة عن امراأة تبلغ من العمر 44 عاما قدمت اإىل عيادة اأمرا�ض الن�ساء يف م�ست�سفى كلية التاأمني احلكومي 
الطبي، فريد اباد، الهند، يف عام 2016 لوجود غزارة يف الطمث. وا�ستنادا اإىل الفح�ض ال�رصيري، مت ت�سخي�سها ب�سكل موؤقت على اأنها حالة 
ورم ليفي يف عنق الرحم. ومع ذلك، ك�سف حتليل اخلزعة وجود مالمح ل�رصطان اخلاليا ال�سغرية للغدد ال�سم الع�سبية يف عنق الرحم. 
مت تاأكيد الت�سخي�ض يف وقت الحق عن طريق الكيمياء الن�سيجية املناعية. يعترب الت�سخي�ض الدقيق ل�رصطان اخلاليا ال�سغرية الغدد ال�سم 
الع�سبية اأمر حيوي الأنه ي�سكل االأ�سا�ض لقرارات العالج وكذلك اإبالغ تنبوؤات احلياة على املدى الطويل.
الكلمات املفتاحية: اأورام الغدد ال�سم الع�سبية؛ �رصطان اخلاليا ال�سغرية؛ عنق الرحم؛ غزارة الطمث؛ ورم ليفي؛ تقرير حالة؛ الهند.
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Primary neuroendocrine tumours (nets) of the female genital tract are extremely rare; among these, only 0.5–1% are cervical.1 A small- 
cell neuroendocrine carcinoma (SNEC) of the cervix 
is a poorly differentiated and highly aggressive tumour 
with a high metastatic propensity.2 On account of its 
dismal prognosis, an early diagnosis of this entity is 
crucial in order to differentiate it from other small- 
cell tumours of the cervix.3 Although histopathology 
remains the mainstay of diagnosis, immunohisto-
chemistry (IHC) also plays a crucial role to both con-
firm the diagnosis as well as ascertain the primary site 
of origin of the tumour.2,3
Case Report
A 44-year-old woman presented to the Gynaecology 
Clinic of the Employees State Insurance Corporation 
Medical College & Hospital, Faridabad, India, in 2016 
with a six-month history of menorrhagia. She had 
had four children and her last birth had taken place 
15 years previously. A speculum examination revealed 
a globular well-defined mass of approximately 4 cm 
which was projecting from the posterior wall of the 
cervix. Upon physical contact, the mass did not bleed 
and did not appear ulcerative or fungating. An ultra-
sound indicated a 3.6 cm hypoechoic area in the upper 
part of the cervical canal, just below the internal orifice 
of the cervix uteri. During examination under anaes-
thesia, a 4 x 3 cm well-defined mass was seen in the 
posterior wall of the cervix and was provisionally diag-
nosed as a fibroid.
A cervical biopsy was performed. Microscopic 
sections showed strips of stratified squamous epith-
elium, of which a few showed dysplasia. The underlying 
tissues exhibited sheets of tumour cells with erythro-
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ated, hypermetabolic lesion involving the cervix and 
lower uterine segment, with likely invasion of the 
vaginal vault and parametrial extension. The mass 
appeared to invade the urinary bladder and rectum. 
Multiple hypermetabolic hypodense lesions were 
present on both lobes of the liver, suggestive of 
metastasis [Figure 3]. The patient was diagnosed with 
a stage IVA SNEC of the cervix. She subsequently 
underwent six cycles of chemotherapy, including 
cisplatin and etoposide. A follow-up PET/CT scan 
suggested a partial response to treatment, with a 
residual metabolically-active primary malignant endo-
cervical lesion as well as metastatic left external iliac 
lymph node and bilobar hepatic parenchymal lesions. 
There was no evidence of any other new lesions.
Discussion
On account of their rarity, primary NETs pose a clinical 
and diagnostic challenge.1,2 Moreover, an accurate 
diagnosis is vital as it forms the basis for treatment 
decisions as well as for predicting long-term survival. 
According to the latest WHO classifications, cervical 
neuroendocrine carcinomas are classified, similarly to 
gastroenteropancreatic neuroendocrine carcinomas, 
into grade 1, grade 2 or grade 3 NETs and into large-
cell or small-cell variants.4,5 In general, SNECs most 
commonly occur in the cervix, with patients ranging 
cyte rosetting in many places [Figure 1A]. The tumour 
cells were small and round, with a high nuclear-cyto-
plasmic ratio and stippled chromatin [Figure 1B]. The 
mitotic rate was very high at >10 mitoses/10 high 
power fields (HPFs). The surrounding stroma showed 
a dense inflammatory infiltrate and many areas of 
haemorrhage and necrosis. These histopathological 
features were consistent with a diagnosis of a SNEC 
of the cervix. This was confirmed by an IHC panel 
revealing strong positivity for synaptophysin, chromo-
granin, pan cytokeratin and p16 [Figure 2]. Neuron-
specific enolase (NSE) was focally positive while stains 
for cluster of differentiation (CD)56 and thyroid trans-
cription factor (TTF)-1 were negative.
Magnetic resonance imaging showed a large ill- 
defined mass in the posterior wall of the cervix, indent- 
ing the cervical canal anteriorly. Fluorine-18-fluorode-
oxyglucose positron emission tomography (PET)/comp-
uted tomography (CT) scans revealed a large, lobul-
 
Figure 1: Haematoxylin and eosin stains at (A) x100 
magnification showing sheets of tumour cells displaying 
erythrocyte rosetting and (B) at x400 magnification 
showing small round tumour cells with a high nuclear-
cytoplasmic ratio and stippled chromatin.
 
Figure 3: Serial fluorine-18-fluorodeoxyglucose positron 
emission tomography/computed tomography scans of 
a 44-year-old woman with a suspected cervical fibroid 
showing a large lobulated hypermetabolic mass involv-
ing the cervix and lower uterine segment. The mass is 
seen to invade the urinary bladder and rectum with mul-
tiple hypermetabolic hypodense lesions in both lobes of 
the liver.
 
Figure 2: Immunohistochemistry photomicrographs 
showing strong positivity for (A) p16 at x400 magnifica-
tion, (B) chromogranin at x100 magnification, (C) synap- 
tophysin at x100 magnification and (D) pan cytokeratin 
at x100 magnification.
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differentiated carcinomas.2 Due to the rarity of SNECs 
of the cervix, it is important to exclude metastasis 
from the lung.3 As cervical fibroids can present 
clinically as a carcinoma or prolapse, cervical carcin-
omas can sometimes be mistaken for fibroids, as in 
the present case.9,10 Seo et al. described a 46-year-old 
woman with metastatic breast cancer spreading to 
the cervix which initially appeared as a large cervical 
fibroid on sonography and was only diagnosed after 
treatment of the primary tumour.11 This may lead to 
grave consequences since fibroids are benign lesions 
which can be cured via surgical excision while carcin- 
omas usually require a multimodal approach involving 
surgery, chemotherapy or radiotherapy, with prognosis 
dependent on the type and stage of the tumour. As such, 
the radiographical evaluation of suspected NETs should 
include CT or PET/CT scans.12
Various combined chemotherapy regimens have 
improved the median survival rate among patients 
with small-cell bronchogenic carcinomas and are now 
being used to treat SNECs of the cervix.13 Hoskins 
et al. reported the successful treatment of a stage 
IA–IVB cervical small-cell carcinoma using chemo-
radiation with etoposide and cisplatin.14 Notably, such 
regimens are generally preferred over those containing 
vincristine, adriamycin and cyclophosphamide as they 
are less toxic. Surgical resection is usually undertaken 
for limited-stage neuroendocrine carcinomas. The use 
of platinum with or without etoposide has also been 
observed to improve survival in SNEC cases.14 An 
advanced stage, tumour size, the presence of lymph 
node metastasis, pure small-cell histology and smoking 
are associated with worse clinical outcomes for patients 
with SNECs.15
Conclusion
Neuroendocrine carcinomas of the cervix, particularly 
small-cell variants, present a clinical and diagnostic 
challenge due to their rarity. Although histopathology 
remains the gold standard for diagnosing neuro-
endocrine carcinomas, IHC is usually required to 
confirm the diagnosis as well as to inform treatment 
decisions and provide prognostic information. This 
case highlights that the clinical presentation of SNECs 
can, on rare occasions, be mistaken with that of a 
cervical fibroid.
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